Eureka Home »
Welcome to Eureka, an online community for scientists to explore, connect and share big ideas.
Read Charles River's scientific blog.
My top priority is the horseshoe crab, a sea creature of little interest in culinary circles but uniquely valuable to biomedical research.
Regulators requiring data on impact of antibody-dependent cellular phagocytosis to better understand monoclonal antibody responses. The final installment in our three-part series.
Meeting the challenges of antibody-dependent cellular phagocytosis with more reliable assays. The second of our three-part series.
Antibody-mediated cellular phagocytosis is often overlooked in analyzing biologics. Find out why in the first of our three-part series about this neglected mechanism of action.
Listen to Charles River scientists share their recent research in these brief podcasts.
In silico simulations and the new paradigm in cardiac toxicity testing.
Getting a novel drug to market is a bit like finishing first in the Boston marathon. It's the ultimate victory in a long, expensive journey. The question is: How many can actually do it?
Biomedical manufacturers and conservationists alike have a vested interest in making sure the Atlantic horseshoe crab, whose ancestry dates back some 440 million years, flourishes.
Tiered approaches have been used in method validation for decades, but to what level CROs are using them in the preclinical arena—particularly early discovery—is difficult to say.
Watch videos from Charles River and our industry colleagues.
My how we've grown. Eureka, Charles River's online community for scientists to explore, connect and share big ideas had a very productive year. Read all about it in our 2014 annual report.